2024
Criteria for PAVM Reintervention
Fish A, Knight E, Henderson K, Pollak J, Schlachter T. Criteria for PAVM Reintervention. Journal Of Clinical Medicine 2024, 13: 6104. PMID: 39458055, PMCID: PMC11508501, DOI: 10.3390/jcm13206104.Peer-Reviewed Original ResearchParadoxical embolismRetrospective review of patientsReview of patientsModern embolization techniquesRetrospective reviewEmbolization techniquesReinterventionScreening intervalEmbolizationLifetime prevalence ratesPatientsRecurrencePAVMsHemoptysisSpontaneous eventsPrevalence ratesCenters of excellenceReperfusionCriteriaFrom transthyretin cardiac amyloidosis diagnosis to tafamidis treatment: Association of drop-off with patient sociodemographic characteristics
Walenczyk K, Singh A, Tong K, Burg M, Miller E. From transthyretin cardiac amyloidosis diagnosis to tafamidis treatment: Association of drop-off with patient sociodemographic characteristics. American Journal Of Health-System Pharmacy 2024, 81: 1245-1251. PMID: 38963826, DOI: 10.1093/ajhp/zxae183.Peer-Reviewed Original ResearchPatient sociodemographic characteristicsATTR-CASociodemographic characteristicsSpecialty pharmacyPyrophosphate scintigraphyPopulation prevalence ratesEconomically disadvantaged areasTransthyretin cardiac amyloidosisBlack/African American raceReduce disparitiesPotential patient subgroupsPharmacy processesProportion of daysClinical pathwayCompare sociodemographicsDisadvantaged areasEquitable provisionTafamidis therapyCardiac amyloidosisTafamidis treatmentPrevalence ratesClinical programsAmerican racePatient subgroupsPosting manuscriptsResearch and publication gaps on kratom and kratom products: a scoping review of current literature
Vicknasingam B, Karunakaran T, Chawarski M. Research and publication gaps on kratom and kratom products: a scoping review of current literature. Current Opinion In Psychiatry 2024, 37: 282-291. PMID: 38818826, DOI: 10.1097/yco.0000000000000950.Peer-Reviewed Original ResearchConceptsHealth system databasePublic health impactPublic health consequencesPrevalence ratesNational surveyHealth impactsPublic healthPublication gapSystem databaseCase series reportControlled clinical studiesClinical case reportEpidemiological factorsEpidemiological surveillanceCase reportScopus databasesSeries reportClinical studiesKratom productsSurveyHuman laboratoryResearch articlesKratomHealthAnalytical studyHypertension Trends and Disparities Over 12 Years in a Large Health System: Leveraging the Electronic Health Records
Brush J, Lu Y, Liu Y, Asher J, Li S, Sawano M, Young P, Schulz W, Anderson M, Burrows J, Krumholz H. Hypertension Trends and Disparities Over 12 Years in a Large Health System: Leveraging the Electronic Health Records. Journal Of The American Heart Association 2024, 13: e033253. PMID: 38686864, PMCID: PMC11179912, DOI: 10.1161/jaha.123.033253.Peer-Reviewed Original ResearchConceptsElectronic health recordsRegional health systemImprove hypertension careHealth systemHealth recordsHypertension careDiastolic blood pressureAge-adjusted prevalence ratesNon-Hispanic Black patientsPrevalence ratesLarger health systemCross-sectional analysisTransformation of medical dataLeveraging real-world dataHigh prevalence rateHypertension trendsHypertension prevalenceBlood pressureBlood pressure measurementsHypertension diagnosisPrimary outcomeNational trendsProportion of patientsAntihypertensive medicationsBlack patients0757 Association of Insomnia with Objective Short Sleep Duration and Other Phenotypes with Mortality in Older Persons
Miner B, Pan Y, Cho G, Knauert M, Yaggi H, Gill T, Stone K, Ensrud K, Zeitzer J, Yaffe K, Doyle M. 0757 Association of Insomnia with Objective Short Sleep Duration and Other Phenotypes with Mortality in Older Persons. Sleep 2024, 47: a324-a325. DOI: 10.1093/sleep/zsae067.0757.Peer-Reviewed Original ResearchAssociated with increased mortality riskAssociation of insomniaMortality riskOlder personsShort sleep durationOsteoporotic fracturesAdjusted modelsStudy of Osteoporotic FracturesSleep durationHigher mortality riskCox proportional hazards modelsMen Sleep StudyNormal sleepProportional hazards modelAssociated with mortalitySevere sleep-disordered breathingUnadjusted modelsUnadjusted analysisCausal pathwaysSleep-disordered breathingFollow-up timePrevalence ratesReference groupHazards modelRisk phenotypesGlobal, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Collaborators G, Wu A, Cross M, Elliott J, Culbreth G, Haile L, Steinmetz J, Hagins H, Kopec J, Brooks P, Woolf A, Kopansky-Giles D, Walton D, Treleaven J, Dreinhoefer K, Betteridge N, Abbasifard M, Abbasi-Kangevari Z, Addo I, Adesina M, Adnani Q, Aithala J, Alhalaiqa F, Alimohamadi Y, Amiri S, Amu H, Antony B, Arabloo J, Aravkin A, Asghari-Jafarabadi M, Atomsa G, Azadnajafabad S, Azzam A, Baghdadi S, Balogun S, Balta A, Banach M, Banakar M, Barrow A, Bashiri A, Bekele A, Bensenor I, Bhardwaj P, Bhat A, Bilchut A, Briggs A, Buchbinder R, Cao C, Chaurasia A, Chirinos-Caceres J, Christensen S, Coberly K, Cousin E, Dadras O, Dai X, de Luca K, Dehghan A, Dong H, Ekholuenetale M, Elhadi M, Eshetu H, Eskandarieh S, Etaee F, Fagbamigbe A, Fares J, Fatehizadeh A, Feizkhah A, Ferreira M, Ferreira N, Fischer F, Franklin R, Ganesan B, Gebremichael M, Gerema U, Gholami A, Ghozy S, Gill T, Golechha M, Goleij P, Golinelli D, Graham S, Haj-Mirzaian A, Harlianto N, Hartvigsen J, Hasanian M, Hassen M, Hay S, Hebert J, Heidari G, Hoveidaei A, Hsiao A, Ibitoye S, Iwu C, Jacob L, Janodia M, Jin Y, Jonas J, Joshua C, Kandel H, Khader Y, Khajuria H, Khan E, Khan M, Khatatbeh M, Khateri S, Kashani H, Khonji M, Khubchandani J, Kim Y, Kisa A, Kolahi A, Koohestani H, Krishan K, Kuddus M, Kuttikkattu A, Lasrado S, Lee Y, Legesse S, Lim S, Liu X, Lo J, Malih N, Manandhar S, Mathews E, Mesregah M, Mestrovic T, Miller T, Mirghaderi S, Misganaw A, Mohammadi E, Mohammed S, Mokdad A, Momtazmanesh S, Moni M, Mostafavi E, Murray C, Nair T, Nejadghaderi S, Nzoputam O, Oh I, Okonji O, Owolabi M, Pacheco-Barrios K, Fallahy M, Park S, Patel J, Pawar S, Pedersini P, Peres M, Petcu I, Pourahmadi M, Qattea I, Ram P, Rashidi M, Rawaf S, Rezaei N, Rezaei N, Saeed U, Sharif-Askari F, Salahi S, Sawhney M, Schumacher A, Shafie M, Shahabi S, Shahbandi A, Shamekh A, Sharma S, Shiri R, Shobeiri P, Sinaei E, Singh A, Singh J, Singh P, Skryabina A, Smith A, Tabish M, Tan K, Tegegne M, Tharwat S, Vahabi S, Tahbaz S, Vasankari T, Venketasubramanian N, Vollset S, Wang Y, Wiangkham T, Yonemoto N, Zangiabadian M, Zare I, Zemedikun D, Zheng P, Ong K, Vos T, March L. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology 2024, 6: e142-e155. PMID: 38383088, PMCID: PMC10897950, DOI: 10.1016/s2665-9913(23)00321-1.Peer-Reviewed Original ResearchConceptsRate of neck painAge-standardised prevalence rateNeck painPrevalence rate of neck painBurden of neck painGlobal burdenBayesian meta-regression toolGlobal Burden of Disease StudyAge-standardised YLD ratesNeck pain prevalenceBurden of Disease StudyGlobal Burden of DiseaseNeck pain casesPrevalence ratesAge-standardised ratesRisk Factors StudySocio-demographic indexMiddle-income countriesPopulation-representative surveyBurden of diseaseBill & Melinda Gates FoundationMedical claims dataAging global populationPain prevalenceDisability burdenInflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019
Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad F, Francis F, Barada K, Tfayli R, Al-Bawardy B, Farraye F, Hashash J. Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019. Annals Of Gastroenterology 2024, 37: 527-535. PMID: 39238799, PMCID: PMC11372542, DOI: 10.20524/aog.2024.0909.Peer-Reviewed Original ResearchIBD burdenGlobal Burden of DiseaseDisability-adjusted life yearsMiddle East and North Africa regionPrevalence rates of inflammatory bowel diseaseAge-standardized mortality ratesRates of inflammatory bowel diseaseEpidemiology of inflammatory bowel diseaseInflammatory bowel disease incidenceMortality rateInflammatory bowel diseaseSex-specific trendsBurden of diseaseAnalysis of incidentsGlobal burdenMiddle East and North AfricaIncidence rateLife yearsDisease burdenPrevalence ratesStudy databasePrevalenceGeographic variationObjective dataBurdenDifferences in Diagnostic Rules Used to Determine Borderline Personality Disorder Impact Prevalence and Associations with Clinically Relevant Variables: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III
Loya J, Wagner A, Pittman B, Davis M. Differences in Diagnostic Rules Used to Determine Borderline Personality Disorder Impact Prevalence and Associations with Clinically Relevant Variables: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Personality Disorders Theory Research And Treatment 2024, 15: 60-73. PMID: 38206863, PMCID: PMC10786338, DOI: 10.1037/per0000643.Peer-Reviewed Original ResearchConceptsBorderline personality disorderBorderline personality disorder diagnosisPrevalence of borderline personality disorderBorderline personality disorder statusClinically relevant variablesNational Epidemiologic SurveyRelated Conditions-IIIMental health conditionsGeneralizability of findingsPersonality disorderClinical interviewClinical variablesProblem behaviorsDisorder prevalenceConditions-IIIRelevant variablesMethodological differencesEpidemiological surveyDisordersBorderlineDiagnostic rulesPrevalence ratesU.S. adultsHealth consequencesHealth conditions
2023
Assessing the Prevalence Rates of Internalizing Symptomatology Among Multiracial Adolescents in the United States: A Systematic Review
Henson-García M, Weerakoon S, Duncan C, Choe T, Opara I, A. Baker K, L. Sterling K, Messiah S. Assessing the Prevalence Rates of Internalizing Symptomatology Among Multiracial Adolescents in the United States: A Systematic Review. Child Psychiatry & Human Development 2023, 1-14. PMID: 38042957, DOI: 10.1007/s10578-023-01636-4.Peer-Reviewed Original ResearchInternalizing symptomsMultiracial adolescentsPrevalence of anxiety symptomsInternalizing symptomatologyAnxiety symptomsDepressive symptomatologySymptomatologyPrevalence estimatesMethodological inconsistenciesAdolescentsSystematic reviewSymptomsPrevalence ratesPeer-reviewed studiesAPA PsycInfoOvid MEDLINEComprehensive searchPrevalenceStudy selectionUnited StatesEpidemiological researchComprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions
van der Horst M, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, Wagner E, consortium C, Müderrisoğlu A, Privat A, Bouhuis A, Hasan A, Jongkind A, Gonzalez-Pinto A, Santacana A, D'Agostino A, Ertugrul A, Yağcioğlu A, Crespo-Facorro B, Sanchez-Barbero B, Spuch C, Morgenroth C, de Pinedo C, Casetta C, Bousman C, Pantelis C, Ovejas-Catalán C, Garcia-Rizo C, Okhuijsen-Pfeifer C, Cohen D, Ristic D, Beld E, Repo-Tiihonen E, Wagner E, Jeger-Land E, Vilella E, Bekema E, Sepúlveda S, Seghi F, Wiedenmann F, Martini F, Serio F, Vairano F, Mercuriali G, Boido G, Yoca G, van Beek H, Gijsman H, Tuppurainen H, Everall I, Novakovic I, Zorrilla I, Erdoğan I, Sapienza J, Bogers J, Tiihonen J, Vázquez-Bourgon J, van Os J, Schneider-Thoma J, Luykx J, Grootens K, Mar-Barrutia L, Martorell L, Bak M, Spangaro M, de Vos M, de Koning M, Garriga M, Lähteenvuo M, Bosia M, van der Horst M, Babaoğlu M, Veereschild M, Manchia M, Edlinger M, Fuentes-Pérez P, Paribello P, Lopez-Pena P, Kahn R, Cavallaro R, Veerman S, Gutwinski S, Schreiter S, Ripke S, Baltanás T, Oviedo-Salcedo T, Hallikainen T, Görlitz T, Alink W, Ayhan Y, Okhuijsen-Pfeifer C, Luykx J. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions. Psychiatry Research 2023, 330: 115539. PMID: 37988817, DOI: 10.1016/j.psychres.2023.115539.Peer-Reviewed Original ResearchConceptsAdverse drug reactionsClinical factorsDrug reactionsPrevalence ratesCommon adverse drug reactionsWeight gainSignificant weight gainMulti-center studyImproved treatment outcomesClozapine blood levelsClozapine monotherapyClozapine treatmentLower BMIBlood levelsTreatment outcomesHigh prevalencePrevalenceMean numberYounger participantsSex differencesParticipantsTreatmentComprehensive dissectionConstipationHypersalivationHospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis
Kwei-Nsoro R, Ojemolon P, Attar B, Shaka H, Zarza-Gulino P, Asare M, Annor E, Mba B. Hospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis. Cureus 2023, 15: e44315. PMID: 37779798, PMCID: PMC10536399, DOI: 10.7759/cureus.44315.Peer-Reviewed Original ResearchTotal hospital chargesNational Inpatient SampleLength of stayJoinpoint regression analysisPrevalence ratesEosinophilic esophagitisHospitalization trendsStudy periodMortality ratePrevalence of EoEInflammatory bowel diseaseAnnual percentage changeAverage prevalence rateRegression analysisHospital-specific variablesPatient demographicsBowel diseaseHospital chargesInpatient DatabaseInpatient SampleMale genderEsophageal mucosaEsophageal diseaseHospitalizationNationwide analysisLeveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees
Nikitin B, Bromberg D, Madden L, Stöver H, Teltzrow R, Altice F. Leveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees. PLOS Global Public Health 2023, 3: e0002168. PMID: 37440470, PMCID: PMC10343058, DOI: 10.1371/journal.pgph.0002168.Peer-Reviewed Original ResearchOpioid use disorderAgonist maintenance therapyMaintenance therapyInjection drug usePrevention of HIVGold standard treatmentRisk of HIVHigh prevalence ratesCare continuityStandard treatmentPrevalence ratesUse disordersImplementation science lensDrug useHarm reductionTreatment modelHIVPatientsClinicTherapyAddiction treatment modelsTreatmentProvidersInvasionInterview participantsDisparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection
Getaneh F, Oliveira C, Pathy S, Sheth S. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection. American Journal Of Obstetrics And Gynecology 2023, 229: 284.e1-284.e10. PMID: 37393012, PMCID: PMC10530237, DOI: 10.1016/j.ajog.2023.06.045.Peer-Reviewed Original ResearchConceptsHospital-based obstetricsNon-Hispanic black womenTrichomonas vaginalis infectionPregnant subgroupsClinic populationSubgroup analysisVaginalis infectionNon-Hispanic white womenGuideline-concordant testingRetrospective cohort studyTrichomonas vaginalisMultivariable logistic regressionSingle marital statusHigh prevalence ratesNon-Hispanic blacksCharacteristics of womenBlack womenHigh rateCohort studyGynecology clinicTobacco smokingGuideline recommendationsEntire cohortAssociated FactorsPrevalence ratesCultural Psychiatry – Specific Considerations in the Mental Health Evaluation of Older Hispanics
Pérez Palmer N, Capó A, Ortega B, Kirwin P, Conroy M. Cultural Psychiatry – Specific Considerations in the Mental Health Evaluation of Older Hispanics. Current Geriatrics Reports 2023, 12: 117-127. DOI: 10.1007/s13670-023-00391-7.Peer-Reviewed Original ResearchMental health evaluationHealth evaluationMental health service utilizationHealth service utilizationAdult Latino populationLatino patientsOptimal careService utilizationPrevalence ratesHispanic adultsTreatment interventionsMental illnessAccurate diagnosisCompetent careSensitive careMental healthOlder HispanicsVulnerable populationsCareUnited StatesMultiple barriersLatino populationTreatmentEthnic groupsPopulationRacial, Ethnic, and Socioeconomic Differences in Food Allergies in the US
Jiang J, Warren C, Brewer A, Soffer G, Gupta R. Racial, Ethnic, and Socioeconomic Differences in Food Allergies in the US. JAMA Network Open 2023, 6: e2318162. PMID: 37314805, PMCID: PMC10267771, DOI: 10.1001/jamanetworkopen.2023.18162.Peer-Reviewed Original ResearchConceptsNon-Hispanic Black individualsNon-Hispanic white individualsParent-reported food allergyFood allergyWhite individualsBlack individualsEpinephrine autoinjector useFood allergy outcomesSurvey-weighted proportionsEmergency department visitsCommon food allergensFood allergy reactionsPopulation-based surveyCross-sectional survey studySimilar symptom presentationsLower ratesAutoinjector useDepartment visitsClinical outcomesPhysician diagnosisAllergy outcomesRepresentative sampleAllergy reactionsMAIN OUTCOMEPrevalence ratesObesity prevalence and variability in management practices for patients with symptomatic peripheral artery disease
Scierka L, Peri-Okonny P, Romain G, Mena-Hurtado C, Smolderen K. Obesity prevalence and variability in management practices for patients with symptomatic peripheral artery disease. Obesity Research & Clinical Practice 2023, 17: 264-268. PMID: 37225553, DOI: 10.1016/j.orcp.2023.05.002.Peer-Reviewed Original ResearchConceptsPeripheral arterial diseaseWeight loss medicationsObesity management strategiesMedian odds ratioDietary counselingLower extremity peripheral arterial diseaseSymptomatic peripheral artery diseaseDietary management strategiesSymptomatic PAD patientsPeripheral artery diseaseObesity prevalence ratesPrevalence of obesityPoor disease outcomeModifiable comorbiditiesPORTRAIT registryPAD patientsArtery diseaseArterial diseaseTreatment modalitiesObesity prevalenceOdds ratioDisease outcomePrevalence ratesPAD managementObesity
2022
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy
Kanner A, Saporta A, Kim D, Barry J, Altalib H, Omotola H, Jette N, O'Brien T, Nadkarni S, Winawer M, Sperling M, French J, Abou-Khalil B, Alldredge B, Bebin M, Cascino G, Cole A, Cook M, Detyniecki K, Devinsky O, Dlugos D, Faught E, Ficker D, Fields M, Gidal B, Gelfand M, Glynn S, Halford J, Haut S, Hegde M, Holmes M, Kalviainen R, Kang J, Klein P, Knowlton R, Krishnamurthy K, Kuzniecky R, Kwan P, Lowenstein D, Marcuse L, Meador K, Mintzer S, Pardoe H, Park K, Penovich P, Singh R, Somerville E, Szabo C, Szaflarski J, Thio K, Trinka E, Burneo J, Project A. Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy. Neurology 2022, 100: e1123-e1134. PMID: 36539302, PMCID: PMC10074468, DOI: 10.1212/wnl.0000000000201671.Peer-Reviewed Original ResearchConceptsMajor depressive disorderFocal epilepsyBipolar disorderSuicidal ideationAnxiety disordersGeneral populationSuicidal attemptsPanic disorderMini International Neuropsychiatric InterviewPrevalence of moodInternational Neuropsychiatric InterviewLogistic regression analysisActive suicidal ideationComparable prevalence ratesSeverity Rating ScaleConsecutive adultsDepressive disorderNeuropsychiatric InterviewEpilepsy evaluationHigh prevalencePrevalence ratesTypes of moodPatientsPsychiatric diagnosisEpilepsyTemporal associations between physical activity and three types of problematic use of the internet: A six-month longitudinal study
Huang P, Chen J, Potenza M, Griffiths M, Pakpour A, Chen J, Lin Y, Hung C, O'Brien K, Lin C. Temporal associations between physical activity and three types of problematic use of the internet: A six-month longitudinal study. Journal Of Behavioral Addictions 2022, 11: 1055-1067. PMID: 36427199, PMCID: PMC9881666, DOI: 10.1556/2006.2022.00084.Peer-Reviewed Original ResearchConceptsPhysical activity levelsPhysical activityActivity levelsTemporal associationInternational Physical Activity Questionnaire-Short FormHigher physical activity levelsLow physical activityQuestionnaire-Short FormPrevalence ratesDaily livingPositive temporal associationHealthy lifestyleLongitudinal survey studyTime pointsLongitudinal studySix-month longitudinal studyShort formAdditional investigationEffects modelProblematic useAssociationPresent studySurvey studyAddiction ScaleOnline surveyPerformance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis
Ghaedi B, Cheng W, Ameri S, Abdulkarim K, Costain N, Zia A, Thiruganasambandamoorthy V. Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis. Canadian Journal Of Emergency Medicine 2022, 24: 611-621. PMID: 35921048, DOI: 10.1007/s43678-022-00332-x.Peer-Reviewed Original ResearchConceptsNon-viable pregnancyPregnancy viabilityViable pregnancyDiagnostic odds ratioProgesterone levelsFirst trimester pregnant patientsSingle serum progesterone levelSingle serum progesteroneUseful prognostic informationSerum progesterone levelsValue of progesteroneSensitivity 91.3Pregnant patientsSymptomatic patientsCochrane DatabaseFirst trimesterSerum progesteronePrognostic informationOdds ratioPrevalence ratesPatientsPregnancySummary estimatesSpecificity 75Predictive valueEpidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019
Ajam A, Shobeiri P, Keykhaei M, Moghaddam S, Momtazmanesh S, Masinaei M, Esfahani Z, Rezaei N, Naderian M, Aminorroaya A, Rashidi M, Rezaei N, Larijani B, Malakan Rad E, Farzadfar F. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019. International Journal Of Cardiology 2022, 363: 202-209. PMID: 35777487, DOI: 10.1016/j.ijcard.2022.06.060.Peer-Reviewed Original ResearchConceptsAge-standardized mortality ratesAge-standardized incidence rateAge-standardized prevalence rateDisability-adjusted life yearsAge-standardized DALY rateMortality rateInfectious disease associated with significant morbidityDALY ratesRisk of infective endocarditisDisease associated with significant morbidityGlobal burdenIncidence rateLife yearsPrevalence ratesEscalating incidenceAge groupsStudy dataInfective endocarditisEpidemiological indicesBurdenSignificant morbidityGBDEndocarditisMortalityProvincial level
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply